Insulin Delivery Device Market by Leading Key Players Analysis, Application and Product Type
The insulin
delivery device market size is projected to reach $15.6 billion by 2022,
growing at a CAGR 6.6% between 2016-2022.The
increasing prevalence of diabetes, growing geriatric population, increasing
prevalence of obesity, technological of drug delivery devices and increasing
awareness of diabetic care are driving the growth of the market.
In terms of
type, the insulin delivery device market is segmented into insulin pen, insulin
syringe, insulin pump and others. The insulin pen segment accounted for the
major market share in the global market in 2015, and the insulin pump segment
is expected to witness the highest growth during 2016-2022.
Request for a
sample of this research report:
Various
initiatives, such as programs, activities and campaigns, are implemented by
IDF, NGOs, diabetes associations and health departments to create awareness among
people regarding effects of diabetes and correct method of treatment is driving
the growth of the insulin delivery device market. One such example is a major
initiative taken at a global level in the form of World Diabetes Day;
celebrated on 14th November each year. World Diabetes Day is a key campaign led
by IDF and its member associations, such as the (American Diabetes Association)
ADA, Diabetes UK, Diabetes Australia, Diabetes South Africa, the Canadian
Diabetes Association (CDA), Diabetes New Zealand, and Diabetic Association of
India.
Make enquiry before
buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=insulin-delivery-devices
Insulin pen
needle has single use, although many diabetic patients re-use needle for
delivery of insulin. The re-use of needle could lead to bacterial growth on the
needle, risk of lipohypertrophy and risk of breaking fine tip of needle.
Similarly, the risk associated with jet injectors are accuracy of insulin
dosage and improper injection. Improper injection of insulin can lead to
altered absorption level of insulin in the blood stream and bruising. Hence,
these risks and complications associated with delivery devices are inhibiting
the growth of the insulin delivery device market.
Competitive
Analysis
Some of the
key companies operating in the insulin
delivery device market include Novo Nordisk A/S, Medtronic PLC, Abbott
Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi S.A., Becton,
Dickinson and Company, F. Hoffmann-La Roche Ltd., Animas Corporation, B. Braun
Melsungen AG, and Ypsomed Holdings AG.
Global
Insulin Delivery Device Market Segmentation
By Type
• Insulin pen
• Insulin syringe
• Insulin pump
• Others
By Region
• North America
o U.S.
o Canada
o Rest of North America
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
• Rest of the World (RoW)
Comments
Post a Comment